NRT Smoking Cessation Aids in Hong Kong, China

October 2022 | 23 pages | ID: N2535F48675EN
Euromonitor International Ltd

Abstracts

In 2022, sales of NRT smoking cessation aids are expected to return to the previous trajectory of moderate current value growth. Part of the reason for this is growing health awareness, with this being propelled by several factors, including COVID-19, which brought health topics to the top of consumers’ minds, as well as strong government support in Hong Kong, highlighting the health dangers of COVID-19 in connection to smoking. A further growth driver in the first half of 2022 was the bill bann...

Euromonitor International's NRT Smoking Cessation Aids in Hong Kong, China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the NRT Smoking Cessation Aids market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

NRT SMOKING CESSATION AIDS IN HONG KONG, CHINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
NRT smoking cessation aids sees moderate growth
NRT patches maintains its leading position in value terms
Slight decline in Hong Kong’s smoking population
PROSPECTS AND OPPORTUNITIES
Public smoking cessation programmes pose a challenge
Uncertainty around partial reversal of e-vapour ban related to re-exports
Dominance of large pharmaceutical companies set to continue
CATEGORY INDICATORS
Table 1 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN HONG KONG, CHINA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources